Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop ...

This culminated in a $500m funding cut to mRNA vaccine research funding, impacting around 22 projects being run at the ...

Total non-dilutive funding of up to USD 159 million upon completion of predefined milestones, including near-term committed ...

The $48 million award, granted through the Advanced Research Projects Agency for Health, will help Kernal take its in vivo ...

Orexo AB (Publ.), (STO:ORX) (OTCQX:ORXOY), todayannounced its wholly owned US subsidiary, Orexo US, Inc., has been awarded USD 8 millionin funding by the Biomedical Advanced Research and Development ...

The sizeable $339 million award from the Biomedical Advanced Research and Development Authority (BARDA) focuses on Cidara's ...

The funding will support the development of OX390, an intranasal rescue medication for adulterated opioid overdoses.

San Diego, USA-based biotech Cidara Therapeutics yesterday revealed it has received an award valued up to $339 million from ...

The Department of Defense funds biomedical research to ensure military and pandemic preparedness. This includes mRNA vaccine ...

Swiss drugmaker Basilea Pharmaceutica has secured a Biomedical Advanced Research and Development Authority BARDA contract of ...

BARDA is canceling $500 million of contracts to develop mRNA vaccines for flu and COVID (HHS) Secretary Robert F. Kennedy Jr.

Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the ...